Mirae Asset Global Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.4K | Buy |
8,083
+1,091
| +16% | +$9.78K | ﹤0.01% | 1192 |
|
|
2025
Q1 | $55K | Buy |
6,992
+90
| +1% | +$707 | ﹤0.01% | 1223 |
|
|
2024
Q4 | $53.2K | Sell |
6,902
-581
| -8% | -$4.48K | ﹤0.01% | 1259 |
|
|
2024
Q3 | $57K | Buy |
7,483
+1,322
| +21% | +$10.1K | ﹤0.01% | 1281 |
|
|
2024
Q2 | $37.6K | Sell |
6,161
-131,913
| -96% | -$806K | ﹤0.01% | 1296 |
|
|
2024
Q1 | $998K | Buy |
138,074
+15,894
| +13% | +$115K | ﹤0.01% | 1540 |
|
|
2023
Q4 | $732K | Buy |
122,180
+7,220
| +6% | +$43.2K | ﹤0.01% | 1778 |
|
|
2023
Q3 | $814K | Sell |
114,960
-7,186
| -6% | -$50.9K | ﹤0.01% | 1631 |
|
|
2023
Q2 | $857K | Buy |
122,146
+1,882
| +2% | +$13.2K | ﹤0.01% | 1656 |
|
|
2023
Q1 | $1M | Buy |
120,264
+31,018
| +35% | +$259K | ﹤0.01% | 1544 |
|
|
2022
Q4 | $1.02M | Buy |
89,246
+77
| +0.1% | +$884 | ﹤0.01% | 1481 |
|
|
2022
Q3 | $1.12M | Buy |
89,169
+33,334
| +60% | +$420K | ﹤0.01% | 1426 |
|
|
2022
Q2 | $591K | Buy |
+55,835
| New | +$591K | ﹤0.01% | 1669 |
|